One Day MD | Evidence-Based Wellness

Why insulin resistance, visceral fat, and metabolic dysfunction quietly drive most modern illnesses — and what actually improves outcomes. This article is a core cluster within the Preventive Medicine & Longevity pillar on OneDayMD. It explains why metabolic health sits upstream of cancer, cardiovascular disease, dementia, kidney failure, and accelerated aging. Executive Overview Over the past 50 years, the global disease burden has shifted from infectious illness to chronic, lifestyle-associated disease . Despite appearing unrelated, most of these conditions share common biological roots: Insulin resistance Visceral adiposity Chronic low-grade inflammation Mitochondrial dysfunction Endothelial damage This article explains why metabolic dysfunction is not just a risk factor, but a unifying driver of modern disease — and why improving metabolic health consistently reduces mortality across populations. What Is Metabolic Health? Metabolic health refers to the body’s ability to: Mainta...

The numbers don’t lie. What we’re witnessing is nothing short of a paradigm shift in obesity treatment—a pharmacological coup d’état against the surgical establishment that dominated this space for decades. Let’s walk through exactly what happened, what the data shows, and what it means. 📈 The Numbers: A Tale of Two Trajectories The central finding is stark and accelerating. Between 2022 and 2024, across a study population of 11.7 million adults with obesity, overweight, or diabetes diagnoses: Metric Change (2022–2024) GLP-1 RA prescriptions +140.4% increase Metabolic bariatric surgery (MBS) −34.1% decrease And here’s the kicker—the decline isn’t just happening. It’s speeding up. 2022 to 2023: MBS fell 14.4% 2023 to 2024: MBS fell 23.0% That’s not a gentle slope. That’s a cliff. The JAMA Surgery research letter extending the timeline through Q3 2025 found things got even worse for the surgical camp: from Q3 2022 to Q3 2025, bariatric surgery procedures plummeted 46.4% among eli...